| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRVL | Common Stock | Options Exercise | $884K | +73K | +9.99% | $12.12* | 804K | 31 Jan 2023 | Direct | |
| transaction | MRVL | Common Stock | Sale | -$1.95M | -46.2K | -5.75% | $42.22 | 757K | 31 Jan 2023 | Direct | F1, F2 |
| holding | MRVL | Common Stock | 88.1K | 31 Jan 2023 | By Family Trusts | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRVL | Employee Stock Option (right to buy) | Options Exercise | $0 | -73K | -100% | $0.00* | 0 | 31 Jan 2023 | Common Stock | 73K | $12.12 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.83 to $42.61, inclusive. The reporting person undertakes to provide Marvell Technology, Inc., any security holder any security holder of Marvell or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to the Form 4. |
| F3 | Held in trusts of which the Reporting Person is the trustee, for the benefit of members of his immediate family. |
| F4 | All of the shares subject to this option are fully vested and exercisable as of the date hereof. |